Technical Analysis for CMPI - Checkmate Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 11.75 6.82% 0.75
CMPI closed up 6.82 percent on Wednesday, November 25, 2020, on 32 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Up Up
Historical CMPI trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
Outside Day Range Expansion 0.00%
20 DMA Resistance Bearish 6.82%
50 DMA Resistance Bearish 6.82%
MACD Bullish Signal Line Cross Bullish 6.82%
Outside Day Range Expansion 6.82%
20 DMA Resistance Bearish 7.21%
50 DMA Resistance Bearish 7.21%
MACD Bearish Signal Line Cross Bearish 7.21%
Older End-of-Day Signals for CMPI ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above 10 DMA about 16 hours ago
10 DMA Resistance 1 day ago
Down 1% 1 day ago
Up 2% 1 day ago
Fell Below Previous Day's Low 1 day ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Checkmate Pharmaceuticals, Inc., a biotechnology company, develops novel immunotherapies for the treatment of cancer. It engages in the field of CpG oligonucleotides and validates an approach that combines the ability of CpG DNA to activate an anti-tumor T-cell response with checkpoint inhibition to overcome a tumor's ability to mute the immune response. The company has strategic alliances with Merck KGaA and Pfizer. Checkmate Pharmaceuticals, Inc. was incorporated in 2015 and is based in Cambridge, Massachusetts.
Medicine Biotechnology Health Cancer Pharmaceutical Industry Treatment Of Cancer Immunotherapy Immune System Cancer Immunotherapy Virotherapy Tumor Immunotherapies Pfizer Checkpoint Inhibitor

Is CMPI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 16.49
52 Week Low 8.61
Average Volume 34,557
200-Day Moving Average 0.00
50-Day Moving Average 11.34
20-Day Moving Average 11.27
10-Day Moving Average 11.04
Average True Range 0.96
ADX 13.88
+DI 15.80
-DI 20.12
Chandelier Exit (Long, 3 ATRs ) 10.61
Chandelier Exit (Short, 3 ATRs ) 12.93
Upper Bollinger Band 12.43
Lower Bollinger Band 10.11
Percent B (%b) 0.71
BandWidth 20.62
MACD Line -0.14
MACD Signal Line -0.20
MACD Histogram 0.0564
Fundamentals Value
Market Cap 253.22 Million
Num Shares 21.6 Million
EPS
Price-to-Sales 0.00
Price-to-Book 2.70
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.45
Resistance 3 (R3) 13.27 12.52 13.16
Resistance 2 (R2) 12.52 12.09 12.61 13.07
Resistance 1 (R1) 12.14 11.82 12.33 12.32 12.97
Pivot Point 11.39 11.39 11.49 11.48 11.39
Support 1 (S1) 11.01 10.96 11.20 11.19 10.53
Support 2 (S2) 10.26 10.69 10.35 10.43
Support 3 (S3) 9.88 10.26 10.34
Support 4 (S4) 10.06